Gut bug tied to fatty liver? scientists launch probe

NCT ID NCT07455149

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will examine whether a specific gut bacterium, Ruminococcus gnavus, and the chemicals it produces are linked to metabolic dysfunction-associated fatty liver disease (MAFLD). Researchers will compare 200 healthy adults and those with MAFLD to understand the connection. No treatments or interventions are given; this is purely an observational study to gather knowledge.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, 510000, China